Seminar & Events Photo Gallary
Eastern Biotech & Life Sciences organized series of seminars
in the last three years. The dates of the upcoming seminars
in 2010 will be listed on our website soon. These seminars
carry Ministry of Health accredited CME which are beneficial
for the physicians, clinicians and other healthcare workers.
Our mission is to create awareness and educate the healthcare
practitioners about the new advancements of genetic research
and inventions. Please find the glimps of our CMEs by clicking
the following links.
| |
1st July 2009
"Cervical Cancer & STIs - Cutting Edge Technologies & Management Strategies" |
|
|
| |
Over 75 doctors
from the UAE attended Continuous Medical Education
Seminar (CME) organized by Eastern Biotech &
Life Sciences on “Cervical Cancer & STIs- Cutting
Edge Technologies & Management Strategies”
 |
|
Dr. Marco Baccant
Executive Director of Dubai Biotechnology
& Research Park, Dubai, UAE |
Cervical cancer is the second most common cancer
among the women worldwide, causing 250,000 deaths
annually (WHO report). According to a report
published by Ministry of Health in 2005, about
43 women die in the UAE alone due to cervical
cancer each year. The number has multiplied
significantly in the last couple of years. The
most recent report suggests, 10 women die each
day in the Middle East among the estimated 650
deaths worldwide. HPV (Human Papilloma Virus)
is the cause of 99.7% of cervical cancer cases
and HPV Genotypes 16 and 18 causes approximately
70% of cervical cancers worldwide. Thus it is
important to clearly identify those women at
increased risk of developing cervical cancer
at an early stage.
The seminar and the workshop were held at Rotana
Towers Hotel, Dubai on 1st July 2009, organized
by Eastern Biotech & Life Sciences, supported
and sponsored by Dubiotech, Glaxo smithcline
& Life Cell International. Ministry of Health,
United Arab Emirates acknowledged and rewarded
the event with 4.0 CME credit points. Dr. Marco
Baccanti, Executive Director of DuBiotech, Dubai
presided over the seminar.
The primary objective of the workshop is to
raise awareness of cervical cancer among the
clinicians and how the latest technologies can
be helpful to detect the deadly disease at an
early stage, thus prevent the fatalities of
such conditions. Speakers suggested that the
combination of liquid based cytology used for
pap smear with the Digene Hybrid capture 2 techniques
for HPV genotyping would be beneficial to detect
the infection and the disease at an early stage.
“HPV infection is very common
in sexually active men and women. It is usually
transient and results only in mild cytological
abnormalities. About 80 % of women between 19
and 30 years clear this infection within months
or years, but in some cases persistent infection
of high risk HPV can lead to the development
of cervical cancer” said Dr. Rihab Awad
from Mitera Clinic, DHCC, Dubai, during her
speech on “The Need of Clinical
Education to Raise an Awareness of HPV Screening
and Cervical Cancer Prevention”.
Dr. Sanjida Ahmed Research Director for Eastern
Biotech & Life Sciences discussed about
various Sexually Transmitted Infections
(STI), diagnostic tools available to
detect them and the cutting edge technologies
recently been utilized and marketed by various
companies around the world to diagnose these
infections. She mentioned that Hybrid Capture
2 DNA Test could be advantageous for the patients
in terms of reducing their physical, mental
and financial load.
Detecting HPV means better understanding of
the risk of cervical cancer was the major focus
of Dr. Dinesh Gupta from National Clinical Reference
Laboratory, New Delhi India. He spoke on “Opportunistic
Screening for Cervical Precancer Lesions”
and informed why the combination screening is
vital for prevention and detection of cervical
cancer. According to Dr. Gupta, combined screening
with liquid based cytology and hybrid capture2
HPV DNA test would identify who’s at risk
for high-grade disease and cancer and reduce
missed disease caused by false-negative Pap
Smear. HPV DNA test is the only FDA approved
test to detect 13 high risk HPVs associated
with virtually all cervical cancer, he added.
HPV vaccine now available is a new powerful
weapon to fight against cervical cancer, Dr.
Rima Abu Omar from Al Zahra Hospital, Sharjah,
emphasized. She also stated that Vaccine
is the Primary Protection against Cervical Cancer
and women as young as 9 years should be vaccinated
before they approach the puberty.
About Eastern Biotech & Life
Sciences:
Eastern Biotech & Life Sciences is
a UAE based Biotechnology Company under the
Dubai Biotechnology and Research Park,
DUBIOTECH, Dubai. The company has a
vision to prevent morbidity and mortality among
individuals and families with or at risk of
genetic, congenital, and/or familial disorders.
Eastern Biotech provides quality screening,
education and family-centered comprehensive
services for the Middle Eastern people. The
company offers the most recent technologies
like Hybrid capture technique combined with
Liquid based cytology for detection of HPV and
detection of other STIs from a single swab sample.
|
|
|
|
|
|
|
